I saw this article in Future of BioPharma (PharmaTimes). Sandoz' Omnitrope is the 1st biosimilar to be recommended for use by the National Institute for Health and Clinical Excellence on the National Health Service.
Omnitrope is a follow on biologic to Pfizer's Genotropin (somatotropin) and the first biosimilar to gain approval in Europe to treat growth problems in children.


From the BioJobBlog more on this topic
http://bit.ly/cbmtsm
Posted by: bigredbruce | 06/02/2010 at 04:00 PM